Ovalbumin-derived peptide-Major Histocompatibility Complex (OVA-pMHC) (OVA-pMHC)

The Ovalbumin-derived peptide-Major Histocompatibility Complex (OVA-pMHC) is a fundamental model system in immunology used to study the mechanisms of antigen recognition and T-cell activation. It consists of specific proteolytic fragments of chicken egg ovalbumin, most notably the SIINFEKL epitope (OVA 257-264), bound to MHC Class I or Class II molecules (Rotzschke et al., 1991, Nature). These complexes are specifically recognized by the T-cell receptors (TCRs) of OVA-specific T cells, such as those from the OT-I (CD8+) and OT-II (CD4+) transgenic mouse lines (Hogquist et al., 1994, Cell). In biological systems, the formation of these complexes is the result of intracellular antigen processing and presentation, serving as a critical signal for the adaptive immune system to identify foreign proteins. While not a direct therapeutic target in humans for most systemic diseases, OVA-pMHC is a primary target in the study of egg allergy, where it triggers IgE-mediated hypersensitivity and anaphylaxis (Mine and Yang, 2008, J. Agric. Food Chem.). In oncology and vaccine research, it serves as a surrogate tumor-associated antigen to evaluate the efficacy of novel immunotherapies, including cancer vaccines, adoptive T-cell transfers, and immune checkpoint inhibitors. Experimental agents interacting with this target include TCR-like antibodies, such as the 25-D1.1 clone, which can detect the SIINFEKL-H-2Kb complex with high specificity for research and diagnostic purposes (Porgador et al., 1997, Immunity). The system remains a gold standard for tracking immune responses with high precision using MHC tetramer technology and flow cytometry.

Other names

SIINFEKL-H-2Kb complexOVA 257-264 peptideOVA 323-339 peptideOvalbumin antigen-MHC complexOVA-specific T-cell ligand

The complex acts as a specific ligand for T-cell receptors (TCRs), where the binding of the peptide-MHC complex to the TCR-CD3 complex triggers intracellular signaling cascades, including ZAP-70 activation and calcium flux, leading to T-cell proliferation, cytokine production, and effector functions (Murphy and Weaver, 2016, Janeway's Immunobiology).